^
Association details:
Biomarker:APC mutation
Cancer:Colorectal Cancer
Drug:G007-LK (TNKS inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Title:

A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth

Excerpt:
Compound G007-LK displays favorable pharmacokinetic properties and inhibits in vivo tumor growth in a subset of APC-mutant CRC xenograft models. 
DOI:
10.1158/0008-5472.CAN-12-4562